Peter Davies

ALZ: Genetic variants can run, but they can’t hide

The Feinstein Institute for Medical Research is targeting genetic risk factors behind Alzheimer’s disease, the first of many steps toward new potential treatments. Feinstein Institute assistant professor Yun Freudenberg-Hua has been awarded a five-year, $600,000 grant by the National Institutes of Health’s National Institute on Aging, supporting her mission to better understand the genetic causes of a disease that inflicts an estimated 5.5 million Americans. Ultimately, the doctor and her staff hope to develop new…


Israel, state officials call for Alzheimer’s initiative

U.S. Rep. Steve Israel and State Assemblyman Charles Lavine joined forces at North Shore-LIJ’s Feinstein R&D center on Tuesday to renew a call to turn the Empire State into a national focal point for Alzheimer’s disease research. Joining the pair: State Sen. David Carlucci, a Democrat from mid-state Clarkstown. The initiative, according to the lawmakers, would mirror California’s approach to stem cell research and that state’s 2004 Stem Cell Research and Cures Act, which among…